88 related articles for article (PubMed ID: 72569)
21. [Bleomycin, a new antitumour antibiotic in the treatment of neoplastic diseases].
Christensen L
Wien Klin Wochenschr; 1972 Nov; 84(46):737-43. PubMed ID: 4117777
[No Abstract] [Full Text] [Related]
22. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
O'Malley BW; Li D; McQuone SJ; Ralston R
Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
[TBL] [Abstract][Full Text] [Related]
23. Genetics and biochemical studies of chloramphenicol-nonproducing mutants of Streptomyces venezuelae carrying plasmid.
Akagawa H; Okanishi M; Umezawa H
J Antibiot (Tokyo); 1979 Jun; 32(6):610-20. PubMed ID: 468736
[TBL] [Abstract][Full Text] [Related]
24. The dasyscyphins A-C and niveulone, new biologically active compounds from the ascomycete Dasyscyphus niveus.
Mierau V; Rojas de la Parra V; Sterner O; Anke T
J Antibiot (Tokyo); 2006 Jan; 59(1):53-6. PubMed ID: 16568719
[TBL] [Abstract][Full Text] [Related]
25. [New trends in studies of the pharmacologic activity of microbial metabolites].
Chmiel A
Postepy Hig Med Dosw; 1989; 43(1):119-60. PubMed ID: 2697872
[TBL] [Abstract][Full Text] [Related]
26. Comparison of intratumoral administration of cisplatin versus bleomycin for treatment of periocular squamous cell carcinomas in horses.
Théon AP; Pascoe JR; Madigan JE; Carlson G; Metzger L
Am J Vet Res; 1997 Apr; 58(4):431-6. PubMed ID: 9099393
[TBL] [Abstract][Full Text] [Related]
27. Syntheses and biological evaluation of indolocarbazoles, analogues of rebeccamycin, modified at the imide heterocycle.
Moreau P; Anizon F; Sancelme M; Prudhomme M; Bailly C; Carrasco C; Ollier M; Sevère D; Riou JF; Fabbro D; Meyer T; Aubertin AM
J Med Chem; 1998 May; 41(10):1631-40. PubMed ID: 9572888
[TBL] [Abstract][Full Text] [Related]
28. New microbial secondary metabolites under preclinical development for cancer treatment.
Umezawa H
Recent Results Cancer Res; 1978; 63():120-34. PubMed ID: 705007
[TBL] [Abstract][Full Text] [Related]
29. [Synthesis, function, and evolutionary origin of secondary metabolites produced by micro-organisms].
Santana C; Segura D; Sánchez S
Rev Latinoam Microbiol; 1994; 36(2):139-58. PubMed ID: 7973181
[TBL] [Abstract][Full Text] [Related]
30. Analysis of anti-PDE3 activity of 2-morpholinochromone derivatives reveals multiple mechanisms of anti-platelet activity.
Abbott BM; Thompson PE
Bioorg Med Chem Lett; 2006 Feb; 16(4):969-73. PubMed ID: 16290931
[TBL] [Abstract][Full Text] [Related]
31. Structure and function of "metalloantibiotics".
Ming LJ
Med Res Rev; 2003 Nov; 23(6):697-762. PubMed ID: 12939790
[TBL] [Abstract][Full Text] [Related]
32. A potential plasmid-curing agent, 8-epidiosbulbin E acetate, from Dioscorea bulbifera L. against multidrug-resistant bacteria.
Shriram V; Jahagirdar S; Latha C; Kumar V; Puranik V; Rojatkar S; Dhakephalkar PK; Shitole MG
Int J Antimicrob Agents; 2008 Nov; 32(5):405-10. PubMed ID: 18718743
[TBL] [Abstract][Full Text] [Related]
33. 2,1,3-Benzothiadiazine derivatives: synthesis and screening versus PDE4 enzyme.
Tait A; Luppi A; Avallone R; Baraldi M
Farmaco; 2005 Aug; 60(8):653-63. PubMed ID: 15963514
[TBL] [Abstract][Full Text] [Related]
34. Production of the antitumor drug epirubicin (4'-epidoxorubicin) and its precursor by a genetically engineered strain of Streptomyces peucetius.
Madduri K; Kennedy J; Rivola G; Inventi-Solari A; Filippini S; Zanuso G; Colombo AL; Gewain KM; Occi JL; MacNeil DJ; Hutchinson CR
Nat Biotechnol; 1998 Jan; 16(1):69-74. PubMed ID: 9447597
[TBL] [Abstract][Full Text] [Related]
35. [The effect of cytostatic therapy with bleomycin and methotrexate on cellular immune reactivity].
Bier J; Nicklisch U; Bitter K
Dtsch Zahnarztl Z; 1978 Dec; 33(12):866-9. PubMed ID: 83231
[TBL] [Abstract][Full Text] [Related]
36. Recent studies on bleomycin.
Umezawa H
Lloydia; 1977; 40(1):67-81. PubMed ID: 69246
[No Abstract] [Full Text] [Related]
37. Enhanced production of microbial metabolites in the presence of dimethyl sulfoxide.
Chen G; Wang GY; Li X; Waters B; Davies J
J Antibiot (Tokyo); 2000 Oct; 53(10):1145-53. PubMed ID: 11132960
[TBL] [Abstract][Full Text] [Related]
38. [Microbial secondary metabolites as inhibitors of pharmaceutically important transferases and oxidoreductases].
Eva B; Mária S
Ceska Slov Farm; 2012 Jun; 61(3):107-14. PubMed ID: 22913826
[TBL] [Abstract][Full Text] [Related]
39. [Molecular regulation of microbial secondary metabolites--a review].
Wang L; Tan H
Wei Sheng Wu Xue Bao; 2009 Apr; 49(4):411-6. PubMed ID: 19621625
[TBL] [Abstract][Full Text] [Related]
40. Recent advances in microbial secondary metabolites: inhibitors of hydrolytic enzymes.
Umezawa H
Adv Exp Med Biol; 1979; 120B():319-40. PubMed ID: 517239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
